A panel of six serum microRNAs, miR-483-5p, miR-19a, miR-29a, miR-20a, miR-24, and miR-25 were shown to potentially discern PDAC-associated diabetes from T2D with an area under the receiver operating characteristic curve (AUC) of 0.902 (Table.1)( Figure 4C ) (102)
BPC-157 has been researched to: Improve healing of many types of wounds Protect intestinal organs and prevents stomach ulcers Combats leaky gut, IBS, gastrointestinal cramps and Crohns disease Accelerate healing of skin burns Work as an anti-inflammatory Maintains integrity of mucosal lining GI tract Repair tissues of GIT, tendons, ligaments, brain, bone, etc
Start prescribing with confidence
[3] Sermorelin was originally approved in the 1990s for GH deficiency but was later discontinued as a commercial drug for business reasons (not due to safety or efficacy concerns)
Tachykinins and their receptors in human malignancies